Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine concentrations in cerebrospinal fluid of patients with Alzheimer's disease
2016-004097-17Phase 4Completed
- Sponsor
- Fakultní nemocnice Hradec Králové
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of memantine in Alzheimer's disease (AD), sponsored by Fakultní nemocnice Hradec Králové. Primary endpoint: Development of sensitive and reproducible assay for memantine. Started Jan 2017; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2016-004097-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004097-17.